• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Two Models of Legalization of Psychedelic Substances: Reasons for Concern.

作者信息

Smith William R, Appelbaum Paul S

机构信息

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Scattergood Program for Applied Ethics of Behavioral Health Care, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

出版信息

JAMA. 2021 Aug 24;326(8):697-698. doi: 10.1001/jama.2021.12481.

DOI:10.1001/jama.2021.12481
PMID:34338743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753745/
Abstract
摘要

相似文献

1
Two Models of Legalization of Psychedelic Substances: Reasons for Concern.迷幻物质合法化的两种模式：令人担忧的原因。
JAMA. 2021 Aug 24;326(8):697-698. doi: 10.1001/jama.2021.12481.
2
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.美国的大麻和迷幻药立法及微量用药兴趣状况。
JAMA Health Forum. 2024 Jun 7;5(6):e241653. doi: 10.1001/jamahealthforum.2024.1653.
3
Treatment of alcoholism using psychedelic drugs: a review of the program of research.使用迷幻药物治疗酒精成瘾：研究项目综述
J Psychoactive Drugs. 1998 Oct-Dec;30(4):381-418. doi: 10.1080/02791072.1998.10399714.
4
A Public-Health-Based Vision for the Management and Regulation of Psychedelics.基于公共卫生的迷幻剂管理与监管愿景。
J Psychoactive Drugs. 2016 Sep-Oct;48(4):243-52. doi: 10.1080/02791072.2016.1202459. Epub 2016 Jul 18.
5
Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017.国家层面的大麻合法化对美国 2004-2017 年酒精和大麻混合使用的影响。
Drug Alcohol Depend. 2021 Jan 1;218:108364. doi: 10.1016/j.drugalcdep.2020.108364. Epub 2020 Oct 18.
6
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.精神科医生在两次专业会议上的迷幻知识和观点：一项探索性调查。
J Psychoactive Drugs. 2022 Jul-Aug;54(3):269-277. doi: 10.1080/02791072.2021.1957183. Epub 2021 Aug 19.
7
Psychedelic Drug Legislative Reform and Legalization in the US.美国迷幻药立法改革与合法化。
JAMA Psychiatry. 2023 Jan 1;80(1):77-83. doi: 10.1001/jamapsychiatry.2022.4101.
8
Admissions to substance use treatment facilities for cannabis use disorder, 2000-2017: Does legalization matter?2000-2017 年大麻使用障碍物质使用治疗设施入院人数：合法化是否重要？
Am J Addict. 2022 Sep;31(5):423-432. doi: 10.1111/ajad.13286. Epub 2022 Apr 2.
9
Direct democracy and the adoption of recreational marijuana legalization in the United States, 2012-2019.直接民主与美国休闲大麻合法化的采纳，2012-2019 年。
Int J Drug Policy. 2022 Apr;102:103583. doi: 10.1016/j.drugpo.2022.103583. Epub 2022 Feb 4.
10
Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.美国有未成年子女的成年人中大麻使用趋势，2004-2017 年：娱乐和医疗用途的州级合法化的影响。
Addiction. 2021 Oct;116(10):2770-2778. doi: 10.1111/add.15472. Epub 2021 Mar 26.

引用本文的文献

1
Ethical Issues and Recommendations in Psychedelic Research and Practice: A Scoping Review.迷幻药研究与实践中的伦理问题及建议：一项范围综述
J Bioeth Inq. 2025 Aug 7. doi: 10.1007/s11673-025-10454-3.
2
Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021-2023.自我报告的过去12个月药物使用情况的地理差异：2021 - 2023年国家药物使用和健康状况快速街道报告结果
Subst Use Misuse. 2025;60(11):1678-1689. doi: 10.1080/10826084.2025.2511242. Epub 2025 Jun 5.
3
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.迷幻疗法在精神科临床实践中的应用：欧洲精神病学协会政策文件
Eur Psychiatry. 2025 Jan 10;68(1):e3. doi: 10.1192/j.eurpsy.2024.1806.
4
Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics.处于危险中的迷幻药：健康的商业决定因素、金融纠葛与人口健康伦理
Public Health Ethics. 2024 Mar 1;17(1-2):24-39. doi: 10.1093/phe/phae002. eCollection 2024 Apr-Jul.
5
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.当前对迷幻药物治疗成瘾的临床研究和医学化的观点：安全性、疗效、局限性和挑战。
CNS Drugs. 2024 Oct;38(10):771-789. doi: 10.1007/s40263-024-01101-3. Epub 2024 Jul 20.
6
Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees.中东和北非移民及难民仪式性使用死藤水后对心理健康和幸福的长期益处。
Front Psychiatry. 2024 Apr 10;15:1279887. doi: 10.3389/fpsyt.2024.1279887. eCollection 2024.
7
A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.与澳大利亚迷幻辅助治疗相关的监管和政策问题分类。
Aust N Z J Psychiatry. 2024 Jul;58(7):571-590. doi: 10.1177/00048674241240597. Epub 2024 Apr 16.
8
A Perspective on Psychedelics as Treatments for Addictions.迷幻剂作为成瘾治疗方法的前景
J Stud Alcohol Drugs. 2024 Sep;85(5):583-588. doi: 10.15288/jsad.23-00032. Epub 2024 Mar 22.
9
National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.美国 2017-2022 年迷幻蘑菇（裸盖菇素）缴获量的国家和地区趋势。
Drug Alcohol Depend. 2024 May 1;258:111086. doi: 10.1016/j.drugalcdep.2024.111086. Epub 2024 Feb 6.
10
The safety of supported psilocybin use in Oregon.俄勒冈州辅助使用裸盖菇素的安全性。
Nat Med. 2024 Jan;30(1):17-18. doi: 10.1038/s41591-023-02727-4.

本文引用的文献

1
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.MDMA 辅助治疗严重 PTSD：一项随机、双盲、安慰剂对照的 3 期研究。
Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10.
2
Trends over time in adult cannabis use: A review of recent findings.成人使用大麻的时间趋势：近期研究结果综述。
Curr Opin Psychol. 2021 Apr;38:80-85. doi: 10.1016/j.copsyc.2021.03.005. Epub 2021 Mar 20.
3
Trial of Psilocybin versus Escitalopram for Depression.迷幻蘑菇与依地普仑治疗抑郁症的试验。
N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994.
4
MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017.2014-2017 年间，欧洲药物紧急网络（Euro-DEN Plus）的急诊部门共接收了 4 年与 MDMA 相关的病例。
Clin Toxicol (Phila). 2021 Feb;59(2):131-137. doi: 10.1080/15563650.2020.1784914. Epub 2020 Jul 17.
5
Psychedelics and Psychedelic-Assisted Psychotherapy.迷幻剂与迷幻辅助心理疗法。
Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26.
6
Psychotic disorders hospitalizations associated with cannabis abuse or dependence: A nationwide big data analysis.与大麻滥用或依赖相关的精神病住院治疗：一项全国性大数据分析。
Int J Methods Psychiatr Res. 2020 Mar;29(1):e1813. doi: 10.1002/mpr.1813. Epub 2019 Dec 5.
7
Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.美国休闲大麻合法化与 2008 年至 2016 年期间大麻使用和大麻使用障碍变化的关联。
JAMA Psychiatry. 2020 Feb 1;77(2):165-171. doi: 10.1001/jamapsychiatry.2019.3254.
8
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.服用裸盖菇素蘑菇后挑战性经历的调查研究：急性和持久的积极与消极后果
J Psychopharmacol. 2016 Dec;30(12):1268-1278. doi: 10.1177/0269881116662634. Epub 2016 Aug 30.
9
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.在美国成年人群体中，使用经典迷幻剂与心理困扰和自杀倾向的减轻有关。
J Psychopharmacol. 2015 Mar;29(3):280-8. doi: 10.1177/0269881114565653. Epub 2015 Jan 13.
10
Psychedelics and mental health: a population study.迷幻剂与心理健康：一项人群研究。
PLoS One. 2013 Aug 19;8(8):e63972. doi: 10.1371/journal.pone.0063972. eCollection 2013.